Altre lingue Novo Nordisk A/S

Azioni

NOVO B

DK0062498333

Prodotti farmaceutici

Mercato chiuso - Nasdaq Copenhagen Altri mercati azionari 17:20:00 21/07/2026			Variaz. 5gg	Var. 1 gen.
324,05 ^DKK	-1,20%		+1,36%	-0,37%

21/07	Cosa sappiamo su prezzi e disponibilità dei farmaci per la perdita di peso mentre Novo fa causa a Lilly	RE
21/07	Novo Nordisk fa causa a Eli Lilly per campagne pubblicitarie ritenute "ingannevoli"	MT

Altre lingue

03:55	PRESS DIGEST-Financial Times - July 22
21/07	Healthcare Shares Rise -- Healthcare Roundup
21/07	What we know of weight-loss drugs' pricing, availability as Novo sues Lilly
21/07	Novo Nordisk launches legal attack on Eli Lilly over misleading comparative advertising
21/07	Novo Nordisk Sues Eli Lilly Over Alleged 'Misleading' Ad Campaigns
21/07	MÄRKTE USA/Wall Street baut Aufschläge aus - Technologiewerte ziehen an
21/07	Novo Nordisk Sues Eli Lilly Over Zepbound, Mounjaro Advertising
21/07	European Stocks Close Higher in Tuesday Trading; Investors Await ECB Rate Decision
21/07	Top Midday Stories: 3M Shares Rise on Strong Guidance; Novo Nordisk Sues Eli Lilly Over GLP-1 Advertising
21/07	Global markets live: Boeing, Eli Lilly, JPMorgan Chase, Tesla, Microsoft…
21/07	Novo Sues Rival Lilly Over Weight-Loss Ads
21/07	Novo Nordisk suing Eli Lilly over GLP-1 'outdated' advertisements
21/07	MÄRKTE USA/Wall Street etwas erholt - Technologiewerte ziehen an
21/07	Wall Street setzt auf zwei fragile Erholungen
21/07	Afternoon Meeting: Wall Street apuesta por dos rebotes frágiles
21/07	Wall Street Bets on Two Fragile Rebounds
21/07	Wall Street richting winst
21/07	Novo Nordisk poursuit Eli Lilly en justice pour publicité mensongère
21/07	Novo Nordisk poursuit Eli Lilly pour "publicité mensongère" aux USA
21/07	Novo Nordisk demanda a Eli Lilly, acusándola de publicidad engañosa
21/07	Novo Nordisk verklagt Rivalen Eli Lilly wegen irreführender Werbung
21/07	MÄRKTE USA/Wall Street vor Erholung - Technologiewerte legen zu
21/07	Novo Nordisk Sues Eli Lilly in US Over Misleading Zepbound, Mounjaro Advertising
21/07	Novo Nordisk dépose plainte contre Eli Lilly
21/07	Novo Nordisk Sues Eli Lilly Over Zepbound, Mounjaro Advertising